Information
-
Trademark
-
90217689
-
Serial Number
90217689
-
Registration Number
7355827
-
International Classifications
-
Filing Date
September 28, 2020
3 years ago
-
Registration Date
April 09, 2024
4 months ago
-
Transaction Date
April 26, 2024
3 months ago
-
Status Date
April 09, 2024
4 months ago
-
Published for Opposition Date
November 23, 2021
2 years ago
-
Location Date
March 06, 2024
5 months ago
-
First Use Anywhere Date
October 01, 2022
a year ago
-
First Use In Commerce Date
October 01, 2022
a year ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
MASON, JARED MICHAEL
-
Attorney Name
Ian W. Gillies
Law Office Assigned Location Code
N10
-
Owners
Mark Drawing Code
3
Mark Identification
AXIAL THERAPEUTICS
Case File Statements
- DM0000: The mark consists of eight circles, each connected to a central donut circle by two horizontal lines at the left and right, one shorter vertical line at the top, one longer vertical line at the bottom, one short diagonal line at the lower-left, one longer diagonal line at the upper-left, one slightly longer diagonal line at the upper-right, and one longer diagonal line at the lower right. To the right of this is the stacked stylized wording "AXIAL THERAPEUTICS" where "AXIAL" is in larger-sized font and "THERAPEUTICS" is in smaller-sized font.
- GS0051: Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
- GS0011: Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
- GS0441: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals
- DS0000: "THERAPEUTICS"
- GS0421: Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
Case File Event Statements
-
10/1/2020 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
11/10/2020 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/11/2020 - 3 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
2/19/2021 - 3 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/25/2021 - 3 years ago
5 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
2/25/2021 - 3 years ago
6 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
2/25/2021 - 3 years ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
2/25/2021 - 3 years ago
8 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
3/22/2021 - 3 years ago
9 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/22/2021 - 3 years ago
10 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/22/2021 - 3 years ago
11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
3/24/2021 - 3 years ago
12 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
9/17/2021 - 2 years ago
13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/17/2021 - 2 years ago
14 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/18/2021 - 2 years ago
15 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/15/2021 - 2 years ago
16 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/3/2021 - 2 years ago
17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
11/23/2021 - 2 years ago
18 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/23/2021 - 2 years ago
19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
1/18/2022 - 2 years ago
20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/17/2022 - 2 years ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
6/17/2022 - 2 years ago
22 - SOU EXTENSION 1 FILED
Type: EXT1
-
6/17/2022 - 2 years ago
23 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
6/21/2022 - 2 years ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/11/2023 - a year ago
25 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
1/11/2023 - a year ago
26 - SOU EXTENSION 2 FILED
Type: EXT2
-
1/11/2023 - a year ago
27 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
1/13/2023 - a year ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
2/17/2023 - a year ago
29 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
2/17/2023 - a year ago
31 - USE AMENDMENT FILED
Type: IUAF
-
3/6/2023 - a year ago
30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
3/6/2023 - a year ago
32 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
6/21/2023 - a year ago
36 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Type: XELR
-
4/4/2023 - a year ago
33 - SU - NON-FINAL ACTION - WRITTEN
Type: CNRT
-
4/4/2023 - a year ago
34 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
4/4/2023 - a year ago
35 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/21/2023 - a year ago
37 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Type: XELG
-
7/18/2023 - a year ago
38 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/4/2023 - 10 months ago
39 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/26/2024 - 5 months ago
40 - ASSIGNED TO LIE
Type: ALIE
-
2/26/2024 - 5 months ago
41 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/26/2024 - 5 months ago
42 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/6/2024 - 5 months ago
43 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
3/7/2024 - 5 months ago
44 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
4/9/2024 - 4 months ago
45 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR